Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-2-12
|
pubmed:abstractText |
Five patients with Parkinson's disease were given a single sublingual dose of apomorphine in 3 mg tablets (2 patients received 18 mg and 3 patients took 39 mg). The therapeutic effect appeared within 33.0 min and lasted 137 min. There was a significant correlation between peak concentration, area under the curve, dose (mg/kg) and the duration of the therapeutic effect.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
493-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1761081-Administration, Sublingual,
pubmed-meshheading:1761081-Aged,
pubmed-meshheading:1761081-Apomorphine,
pubmed-meshheading:1761081-Female,
pubmed-meshheading:1761081-Humans,
pubmed-meshheading:1761081-Male,
pubmed-meshheading:1761081-Middle Aged,
pubmed-meshheading:1761081-Parkinson Disease
|
pubmed:year |
1991
|
pubmed:articleTitle |
Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease.
|
pubmed:affiliation |
Clinique Neurologique, CHU Clermont Ferrand, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|